Literature DB >> 19070596

Formation of prebeta1-HDL during lipolysis of triglyceride-rich lipoprotein.

Osamu Miyazaki1, Isamu Fukamachi, Atsuo Mori, Hideyuki Hashimoto, Masa-aki Kawashiri, Atsushi Nohara, Tohru Noguchi, Akihiro Inazu, Masakazu Yamagishi, Hiroshi Mabuchi, Junji Kobayashi.   

Abstract

Prebeta1-HDL, a putative discoid-shaped high-density lipoprotein (HDL) is known to participate in the retrieval of cholesterol from peripheral tissues. In this study, to clarify potential sources of this lipoprotein, we conducted heparin injection on four Japanese volunteer men and found that serum triglyceride (TG) level decreased in parallel with the increase in serum nonesterified fatty acids and plasma lipoprotein lipase (LPL) protein mass after heparin injection. Plasma prebeta1-HDL showed considerable increases at 15 min after the heparin injection in all of the subjects. In contrast, serum HDL-C levels did not change. Gel filtration with fast protein liquid chromatography system (FPLC) study on lipoprotein profile revealed that in post-heparin plasma, low-density lipoprotein and alphaHDL fractions did not change, whereas there was a considerable decrease in very low-density lipoprotein (VLDL) fraction and an increase in prebeta1-HDL fraction when compared with those in pre-heparin plasma. We also conducted in vitro analysis on whether prebeta1-HDL was produced during VLDL lipolysis by LPL. One hundred microliters of VLDL extracted from pooled serum by ultracentrifugation was incubated with purified bovine milk LPL at 37 degrees C for 0-120 min. Prebeta1-HDL concentration increased in a dose dependent manner with increased concentration of added LPL in the reaction mixture and with increased incubation time, indicating that prebeta1-HDL was produced during lipolysis of VLDL by LPL. Taken these in vivo and in vitro analysis together, we suggest that lipolysis of VLDL particle by LPL is an important source for formation of prebeta1-HDL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070596     DOI: 10.1016/j.bbrc.2008.11.146

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Relationships between serum lipid, lipoprotein, triglyceride-rich lipoprotein, and high-density lipoprotein particle concentrations in post-renal transplant patients.

Authors:  Elzbieta Kimak; Magdalena Hałabiś; Iwona Baranowicz-Gaszczyk
Journal:  J Zhejiang Univ Sci B       Date:  2010-04       Impact factor: 3.066

2.  Levels of high-density lipoprotein cholesterol (HDL-C) among children with steady-state sickle cell disease.

Authors:  Magda O Seixas; Larissa C Rocha; Mauricio B Carvalho; Joelma F Menezes; Isa M Lyra; Valma M L Nascimento; Ricardo D Couto; Ájax M Atta; Mitermayer G Reis; Marilda S Goncalves
Journal:  Lipids Health Dis       Date:  2010-08-27       Impact factor: 3.876

3.  Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma.

Authors:  Osamu Miyazaki; Jun Ogihara; Isamu Fukamachi; Takafumi Kasumi
Journal:  J Lipid Res       Date:  2013-12-04       Impact factor: 5.922

4.  The influence of decreased levels of high density lipoprotein cholesterol on hematological indices in sickle cell disease patients.

Authors:  Am Emokpae; A Kuliya-Gwarzo
Journal:  Ann Med Health Sci Res       Date:  2014-03

Review 5.  Efficacy of Polyphenols in the Management of Dyslipidemia: A Focus on Clinical Studies.

Authors:  Francis Feldman; Mireille Koudoufio; Yves Desjardins; Schohraya Spahis; Edgard Delvin; Emile Levy
Journal:  Nutrients       Date:  2021-02-19       Impact factor: 5.717

6.  An in-silico model of lipoprotein metabolism and kinetics for the evaluation of targets and biomarkers in the reverse cholesterol transport pathway.

Authors:  James Lu; Katrin Hübner; M Nazeem Nanjee; Eliot A Brinton; Norman A Mazer
Journal:  PLoS Comput Biol       Date:  2014-03-13       Impact factor: 4.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.